Insufficient scRNA-seq data for expression of CYP11B2 at single-cell level.
Insufficient scRNA-seq data for expression of CYP11B2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 22370.14 | 258 / 258 | 32% | 15.03 | 74 / 230 |
spleen | 54% | 2.48 | 131 / 241 | 0% | 0 | 0 / 0 |
bladder | 48% | 1.62 | 10 / 21 | 0% | 0 | 0 / 504 |
liver | 46% | 4.14 | 103 / 226 | 1% | 0.92 | 6 / 406 |
uterus | 34% | 4.79 | 57 / 170 | 0% | 0 | 0 / 459 |
pancreas | 30% | 1.58 | 99 / 328 | 1% | 0.06 | 1 / 178 |
ovary | 31% | 1.95 | 55 / 180 | 0% | 0 | 0 / 430 |
kidney | 30% | 2.25 | 27 / 89 | 0% | 0 | 0 / 901 |
esophagus | 28% | 2.01 | 401 / 1445 | 1% | 0.01 | 1 / 183 |
stomach | 27% | 1.51 | 97 / 359 | 0% | 0.00 | 1 / 286 |
intestine | 25% | 1.26 | 243 / 966 | 0% | 0.00 | 1 / 527 |
prostate | 25% | 1.66 | 62 / 245 | 0% | 0 | 0 / 502 |
thymus | 25% | 2.16 | 161 / 653 | 0% | 0 | 0 / 605 |
lung | 24% | 1.60 | 138 / 578 | 0% | 0.01 | 2 / 1155 |
brain | 23% | 3.61 | 616 / 2642 | 0% | 0 | 0 / 705 |
breast | 21% | 1.02 | 97 / 459 | 0% | 0.00 | 1 / 1118 |
peripheral blood | 20% | 1.35 | 189 / 929 | 0% | 0 | 0 / 0 |
adipose | 19% | 1.34 | 230 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 18% | 4.89 | 246 / 1335 | 0% | 0 | 0 / 0 |
heart | 18% | 1.51 | 155 / 861 | 0% | 0 | 0 / 0 |
skin | 18% | 1.13 | 321 / 1809 | 0% | 0.02 | 1 / 472 |
muscle | 17% | 0.94 | 133 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035865 | Biological process | cellular response to potassium ion |
GO_0003091 | Biological process | renal water homeostasis |
GO_0034650 | Biological process | cortisol metabolic process |
GO_0055078 | Biological process | sodium ion homeostasis |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0006704 | Biological process | glucocorticoid biosynthetic process |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0016125 | Biological process | sterol metabolic process |
GO_0055075 | Biological process | potassium ion homeostasis |
GO_0006700 | Biological process | C21-steroid hormone biosynthetic process |
GO_0002017 | Biological process | regulation of blood volume by renal aldosterone |
GO_0034651 | Biological process | cortisol biosynthetic process |
GO_0071375 | Biological process | cellular response to peptide hormone stimulus |
GO_0006705 | Biological process | mineralocorticoid biosynthetic process |
GO_0032342 | Biological process | aldosterone biosynthetic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0047783 | Molecular function | corticosterone 18-monooxygenase activity |
GO_0004507 | Molecular function | steroid 11-beta-monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0008395 | Molecular function | steroid hydroxylase activity |
Gene name | CYP11B2 |
Protein name | Steroid 18-hydroxylase Cytochrome P450 11B2, mitochondrial (Aldosterone synthase) (ALDOS) (Aldosterone-synthesizing enzyme) (CYPXIB2) (Corticosterone 18-monooxygenase, CYP11B2) (EC 1.14.15.5) (Cytochrome P-450Aldo) (Cytochrome P-450C18) (Steroid 11-beta-hydroxylase, CYP11B2) (EC 1.14.15.4) (Steroid 18-hydroxylase) |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase that catalyzes the biosynthesis of aldosterone, the main mineralocorticoid in the human body responsible for salt and water homeostasis, thus involved in blood pressure regulation, arterial hypertension, and the development of heart failure . Catalyzes three sequential oxidative reactions of 11-deoxycorticosterone (21-hydroxyprogesterone), namely 11-beta hydroxylation, followed by two successive oxidations at C18 yielding 18-hydroxy and then 18-oxo intermediates (that would not leave the enzyme active site during the consecutive hydroxylation reactions), ending with the formation of aldosterone . Can also produce 18-hydroxycortisol and 18-oxocortisol, derived from successive oxidations of cortisol at C18, normally found at very low levels, but significantly increased in primary aldosteronism, the most common form of secondary hypertension . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin) . Could also be involved in the androgen metabolic pathway (Probable). . |
Accessions | Q16316 ENST00000323110.2 Q16315 P19099 |